Emerging markets to see mixed health spending growth | Asian Business Review
157 views
Photo from Envato

Emerging markets to see mixed health spending growth

India and Turkiye are experiencing sharp increases in expenditure.

Health expenditure growth in emerging markets is projected to show mixed patterns this year, according to a BMI report.

India, Turkiye, and Brazil are experiencing sharp increases in spending due to a rise in inflationary pressures rather than structural market expansion.

Meanwhile, major markets like Mainland China, Mexico, and Russia are exhibiting the expected marginal slowdown in growth.

“A report released by the WHO in April confirms that widespread official development assistance cuts—particularly by the US—have disrupted health systems across more than 80% of surveyed low- and middle-income countries,” the report said.

In response, several Sub-Saharan African governments have increased their health budgets to maintain essential services.

Follow the link for more news on

Join Asian Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you design and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

What lies ahead for South Korea’s medical device market?
The government is investing over $622.1m to support next-generation medical devices.
Healthcare
Smart ports market to reach $15.5b by 2032
This will be driven by IoT, automation, and trade expansion.
China’s new coal power approvals decline in 9M
If this trend continues, 2025 will be the second-lowest year for approvals.